Here a few resources related to psychotropic medications that we believe will improve patient care. Please contact us if you have any questions about any of this information.
Click here to go back to the main resources page.
Behavioral Health Evaluation
This document is intended to serve as a template for a behavioral health committee meeting in an extended care facility. The State Operations Manual (SOM), Appendix PP - "Guidance to Surveyors for Long Term Care Facilities" (F309 Quality of Care and F329 Unnecessary Drugs) were the foundation in which this template was created.
Sections of this document include:
- Part 1: Pharmacist (Meeting Preparation)
- Part 2: Social Services / Nursing (Meeting Preparation)
- Part 3: Social Services (Meeting Preparation)
- Part 4: Behavioral Health Committee Meeting Documentation
- Part 5: Clinical Contraindication Documentation (Psychopharmacologic Therapy, Sedative / Hypnotic Medications, Antipsychotic Medication)
Click here to view these forms (pdf).TOP
National Partnership to Improve Dementia Care in Nursing Homes
The National Partnership to Improve Dementia Care in Nursing Homes is committed to improving the quality of care for individuals with dementia living in nursing homes. The National Partnership has a mission to deliver health care that is person-centered, comprehensive and interdisciplinary with a specific focus on protecting residents from being prescribed antipsychotic medications unless there is a valid, clinical indication and a systematic process to evaluate each individual’s need. The Centers for Medicare & Medicaid Services (CMS) promotes a multidimensional approach that includes; research, partnerships and state-based coalitions, revised surveyor guidance, training for providers and surveyors and public reporting.
CMS is tracking the progress of the National Partnership by reviewing publicly reported measures. The official measure of the Partnership is the percentage of long-stay nursing home residents who are receiving an antipsychotic medication, excluding those residents diagnosed with schizophrenia, Huntington's Disease or Tourette’s Syndrome. In 2011Q4, 23.9 percent of long-stay nursing home residents were receiving an antipsychotic medication; since then there has been a decrease of 33.2 percent to a national prevalence of 16 percent in 2016Q4. Success has varied by state and CMS region, with many states and regions having seen a reduction of greater than 30 percent.
Click here to view the pdf data.
Click here to compare to previous quarters.
We strongly encourage participation in the National Partnership to Improve Dementia Care in Nursing Homes. This data is provided by them quarterly, along with educational webinars which promote various successful strategies used by nursing homes across the states. The webinars have always been a resource to our teams, allowing us to critically analyze our approach and implement others when it was obvious they were superior.
Click here for the National Partnership to Improve Dementia Care's NEW website. Click here for the repository of tools and resources associated with the Partnership.
News & Events
2015 Forum on Aging
& Annual Meeting
March 3 - 4, 2015
Council on Aging of Southwestern Ohio
2015 Spring Conference
& Trade Show
May 4-5, 2015
LeadingAge IndianaMore Details